XM tidak memberikan layanan kepada penduduk Amerika Serikat.
C
C

Cigna


Berita

U.S. STOCKS AppLovin, Regal Rexnord, Talkspace

BUZZ-U.S. STOCKS ON THE MOVE- AppLovin, Regal Rexnord, Talkspace Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose on Tuesday, with the S&P 500 hitting an intraday record high ahead of a crucial Federal Reserve interest-rate decision, after fresh economic data allayed worries of a sharp slowdown in the U.S.
A
C
I
M
N
S
U
U
D

Express Scripts sues FTC over drug pricing report, court documents show

UPDATE 2-Express Scripts sues FTC over drug pricing report Adds detail from the complaint and FTC comment in paragraphs 4-8, updates headline, byline and dateline By Jody Godoy NEW YORK, Sept 17 (Reuters) - Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report , calling the report's conclusion that the prescription middlemen raise drug costs defamatory.
C

Express Scripts sues FTC over drug pricing report, court documents show

Express Scripts sues FTC over drug pricing report, court documents show WASHINGTON, Sept 17 (Reuters) - Pharmacy benefit manager Express Scripts has sued the U.S. Federal Trade Commission over the regulator's recent drug pricing report , asking a court to force the agency to withdraw its findings, according to court documents filed on Tuesday. Repo
C

U.S. Aerovironment, Insulet, Viasat

U.S. RESEARCH ROUNDUP- Aerovironment, Insulet, Viasat Sept 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovironment, Insulet and Viasat, on Tuesday. HIGHLIGHTS * Aerovironment Inc AVAV.O : Raymond James cuts to market perform from outperform * Frontier Communications Parent Inc FYBR.O : JP Morgan cuts to neutral from overweight * Insulet Corp PODD.O : Piper Sandler raises target price to $285 from $230 * Relm
B
C
C
E
I
D

US employers expect nearly 6% spike in health insurance costs in 2025, Mercer says

US employers expect nearly 6% spike in health insurance costs in 2025, Mercer says By Amina Niasse NEW YORK, Sept 12 (Reuters) - U.S. employers expect health insurance costs to rise an average 5.8% in 2025, largely due to increased cost of medical services as well as higher use, according to a survey released by consulting firm Mercer on Thursday.
C

Cigna Healthcare Makes Virtual Care Even Easier And More Convenient With New E-Treatment Option From MDLIVE

BRIEF-Cigna Healthcare Makes Virtual Care Even Easier And More Convenient With New E-Treatment Option From MDLIVE Sept 12 (Reuters) - Cigna Group CI.N : CIGNA HEALTHCARE MAKES VIRTUAL CARE EVEN EASIER AND MORE CONVENIENT WITH NEW E-TREATMENT OPTION FROM MDLIVE Source text for Eikon: ID:nPn2lrgZga Further company coverage: CI.N
C

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year By Patrick Wingrove Sept 10 (Reuters) - UnitedHealth Group UNH.N said on Tuesday it will remove AbbVie’s ABBV.N blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of Jan. 1, 2025, and recommend less expensive biosimilar versions of the medicine instead.
A
C
P
T

Portion of insured Americans was 92% in 2023, Census data shows

UPDATE 2-Portion of insured Americans was 92% in 2023, Census data shows Adds context on data in paragraph 3 and Medicare figure in paragraph 6 By Amina Niasse NEW YORK, Sept 10 (Reuters) - The portion of Americans who had health insurance for all or part of the year in 2023 was 92%, compared with 92.1% for all or part of 2022 according to a report released by the Census Bureau on Tuesday.
C

Proportion of Americans with health insurance was at 92% in 2023, Census data shows

Proportion of Americans with health insurance was at 92% in 2023, Census data shows NEW YORK, Sept 10 (Reuters) - The portion of Americans who had health insurance for all or part of the year fell slightly in 2023 to 92%, compared with 92.1% for all or part of 2022 according to a report released by the Census Bureau on Tuesday. The rate of Americans who are uninsured is set to rise to 8.9% over the next decade from 7.7% in 2024, the Congressional Budget Office said in a separate report released
C

More than 49 million in US covered by ACA over the past decade

More than 49 million in US covered by ACA over the past decade By Amina Niasse NEW YORK, Sept 10 (Reuters) - One in seven Americans have signed up for health insurance coverage through Affordable Care Act marketplaces since their 2014 launch, according to data released on Tuesday by the U.S. Department of the Treasury. A total of 49.4 million Americans have signed up for the plans, often referred to as Obamacare, with enrollment reaching a high of 20.8 million people in 2024, the agency said.
C

Biden administration finalizes rule to strengthen mental health parity law

Biden administration finalizes rule to strengthen mental health parity law By Amina Niasse NEW YORK, Sept 9 (Reuters) - The Biden Administration on Monday said it had finalized regulation to help ensure the 175 million Americans with private health insurance have access to affordable mental health services. The 2008 Mental Health Parity and Addiction Equity Act already requires insurers and corporate-backed health plans to provide access and payment structures for mental health care services on
C

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year By Patrick Wingrove Aug 26 (Reuters) - Cigna CI.N said on Monday it will remove AbbVie’s ABBV.N blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey biosimilar versions of the medicine instead.
A
C
P
T

U.S. Agree Realty, Global Payments, Snowflake

U.S. RESEARCH ROUNDUP- Agree Realty, Global Payments, Snowflake Aug 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agree Realty, Global Payments and Snowflake on Wednesday. HIGHLIGHTS * Agree Realty Corp ADC.N : Raymond James raises target price to $81 from $70 * Coinbase Global Inc COIN.O : Jefferies cuts target price to $220 from $245 * Global Payments Inc GPN.N : Jefferies raises target price to $130 from $120
A
B
C
C
P
V
E
G
M
K
L

Venture capital firms making bets on maternal health

FOCUS-Venture capital firms making bets on maternal health By Amina Niasse NEW YORK, Aug 19 (Reuters) - After working as a doula for 10 years, Kortny Feutardo took her first Maryland Medicaid patient in January, providing the new mom with care coordination and counseling. Feutardo is one of many providers benefiting from growing investment in the maternal and neonatal health sector .
C

The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health

BRIEF-The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health Aug 12 (Reuters) - Cigna Group CI.N : THE CIGNA GROUP FOUNDATION LAUNCHES GRANT PROGRAM TO IMPROVE VETERAN MENTAL HEALTH Source text for Eikon: ID:nPn2HqD7a Further company coverage: CI.N ( Reuters.Briefs@thomsonreuters.com )
C

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals

U.S. RESEARCH ROUNDUP- Booking Holdings, Doordash, Vertex Pharmaceuticals Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday. HIGHLIGHTS * Academy Sports and Outdoors Inc ASO.O : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Jefferies cuts target price to $4350 from $4650 * Doordash DASH.O : D.A.
A
B
C
C
C
C
E
V
E
A
B
C
C
C
C

Cigna falls after unchanged annual forecast despite profit beat

BUZZ-Cigna falls after unchanged annual forecast despite profit beat ** Shares of health insurer Cigna fall 4.8% to $331.80 ** Set for biggest one-day pct. fall since Nov. 2023 ** Co maintains its annual profit forecast after Q2 profit beat ** The lack of forecast raise despite the beat will be likely viewed as a modest disappointment - Leerink Partners ** Brokerage expects investors to keenly focus on determining if this resulted from more prudent posturing or a synthetic guide-down of the seco
C

Health insurer Cigna's cautious annual forecast spooks investors, shares fall

UPDATE 2-Health insurer Cigna's cautious annual forecast spooks investors, shares fall New throughout, adds details, background, analyst comments, updates share price By Amina Niasse and Sriparna Roy Aug 1 (Reuters) - Cigna CI.N took a cautious stance on its full-year profit outlook on Thursday despite reporting lower-than-feared medical costs in the second quarter and beating Wall Street's profit estimates, and the health insurer's shares fell more than 4%.
C

Fed nods to cut, chips rebound, BoE up next

MORNING BID AMERICAS-Fed nods to cut, chips rebound, BoE up next A look at the day ahead in U.S. and global markets from Mike Dolan The Federal Reserve left Wall Street with little doubt about a first U.S. interest rate cut in seven weeks' time, but multiple cross-currents from the earnings season , Japan and China, and domestic politics all make for a noisy start to August.
A
A
A
B
C
G
I
N
R
U
X
M
J
U
U
U
F
E
W
A
M

Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost

Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost Aug 1 (Reuters) - Cigna CI.N reported a second-quarter profit on Thursday that beat Wall Street estimates, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit. The industry has been contending with elevated medical costs since late last year, as older adults catch up on delayed procedures, and lower-than-expected payments from the government for managing healthcare for p
C



Kondisi

Aset Populer

Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.

Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.

Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.

Peringatan Resiko: Modal Anda beresiko. Produk dengan leverage mungkin tidak cocok bagi semua orang. Silahkan pertimbangkan Pengungkapan Resiko kami.